Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

Background. Angiotensin-(1-7) [Ang-(1-7)] is an endogenous antiangiogenic hormone with anticancer activity. In a phase I study of Ang-(1-7), two of three patients with metastatic sarcoma experienced disease stabilization. This phase II study examined clinical and biomarker outcomes for patients with...

全面介紹

Na minha lista:
書目詳細資料
發表在:Sarcoma
Main Authors: Savage, Paul D., Lovato, James, Brosnihan, K. Bridget, Miller, Antonius A., Petty, W. Jeffrey
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2016
主題:
Clinical Study
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118533/
https://ncbi.nlm.nih.gov/pubmed/27895527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4592768
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍